pubrio
Avril Biopharma, Inc.

Avril Biopharma, Inc.

United States · Biotechnology Research

Biotechnology Research

Avril Biopharma, Inc. uses novel bioinformatics and recombinant gene technologies to design, build and manufacture next-generation molecular medicines. Our mission is to transform the speed, safety and economy with which new vaccine, therapeutic, and gene-therapy products can be brought to the clinic. Our Structural Genetics ™ bioinformatics and AdCEV ™ /Egg protein expression platform are integrated to improve discovery, molecular engineering, product testing, scaling and deployment-- for one person or for millions. We offer our services to help address two industry challenges: 1. Rapid design, development and production of vaccines, therapeutics, biosimilars & diagnostics for global health and emerging disease threats and; 2. Customized drugs for personalized medicine and gene therapy (anti-cancer vaccines, gene-therapy drugs). We are building an end-to-end platform for rapid, rational development of emergency vaccines, on-demand personalized medicines and other therapeutic and diagnostic products.

Company Insights
Company Overview

2017

Founded

Biotechnology Research

Industry

United States

Location

11,960,565

Ranking

3 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Avril Biopharma, Inc.

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​